| 000 | 01787 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518082826.0 | ||
| 264 | 0 | _c20200310 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1612-1880 | ||
| 024 | 7 |
_a10.1002/cbdv.201900659 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnanth, Arjun H | |
| 245 | 0 | 0 |
_aDesign, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents. _h[electronic resource] |
| 260 |
_bChemistry & biodiversity _cFeb 2020 |
||
| 300 |
_ae1900659 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA (Cytosine-5-)-Methyltransferase 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aEstrogen Receptor alpha _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xpharmacology |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aOxadiazoles _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aManikandan, Natarajan | |
| 700 | 1 | _aRajan, Ravi Kumar | |
| 700 | 1 | _aElancheran, Ramakrishnan | |
| 700 | 1 | _aLakshmithendral, Kunasekaran | |
| 700 | 1 | _aRamanathan, Muthiah | |
| 700 | 1 | _aBhattacharjee, Atanu | |
| 700 | 1 | _aKabilan, Senthamaraikannan | |
| 773 | 0 |
_tChemistry & biodiversity _gvol. 17 _gno. 2 _gp. e1900659 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cbdv.201900659 _zAvailable from publisher's website |
| 999 |
_c30573500 _d30573500 |
||